447 related articles for article (PubMed ID: 23859232)
21. Leukotriene modifiers in the treatment of cardiovascular diseases.
Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
[TBL] [Abstract][Full Text] [Related]
22. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
Rubin P; Mollison KW
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
[TBL] [Abstract][Full Text] [Related]
24. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends.
Capra V; Thompson MD; Sala A; Cole DE; Folco G; Rovati GE
Med Res Rev; 2007 Jul; 27(4):469-527. PubMed ID: 16894531
[TBL] [Abstract][Full Text] [Related]
25. Molecular and functional aspects of human cysteinyl leukotriene receptors.
Capra V
Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
[TBL] [Abstract][Full Text] [Related]
26. Role of Leukotrienes and Leukotriene Modifiers in Asthma.
Montuschi P
Pharmaceuticals (Basel); 2010 Jun; 3(6):1792-1811. PubMed ID: 27713330
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
28. Leukotriene E
Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
[TBL] [Abstract][Full Text] [Related]
29. Cysteinyl leukotriene receptors.
Evans JF
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():587-97. PubMed ID: 12432945
[TBL] [Abstract][Full Text] [Related]
30. Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
Sekioka T; Kadode M; Fujii M; Kawabata K; Abe T; Horiba M; Kohno S; Nabe T
Allergol Int; 2015 Oct; 64(4):351-8. PubMed ID: 26433531
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of tenascin and laminin beta2 chain in human bronchial epithelial cells is enhanced by cysteinyl leukotrienes via CysLT1 receptor.
Altraja S; Kadai M; Rekker E; Altraja A
Respir Res; 2008 May; 9(1):44. PubMed ID: 18503712
[TBL] [Abstract][Full Text] [Related]
32. A new CysLT
Sekioka T; Kadode M; Osakada N; Fujita M; Matsumura N; Yamaura Y; Nakade S; Nabe T; Kawabata K
Prostaglandins Leukot Essent Fatty Acids; 2017 Apr; 119():18-24. PubMed ID: 28410666
[TBL] [Abstract][Full Text] [Related]
33. Expanding roles for leukotrienes in airway inflammation.
Peters-Golden M
Curr Allergy Asthma Rep; 2008 Jul; 8(4):367-73. PubMed ID: 18606091
[TBL] [Abstract][Full Text] [Related]
34. New perspectives for asthma treatment: anti-leukotriene drugs.
García-Marcos L; Schuster A
Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
36. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites.
Mechiche H; Naline E; Candenas L; Pinto FM; Birembault P; Advenier C; Devillier P
Clin Exp Allergy; 2003 Jul; 33(7):887-94. PubMed ID: 12859443
[TBL] [Abstract][Full Text] [Related]
37. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
38. Functional expression of cysteinyl leukotriene receptors on human platelets.
Hasegawa S; Ichiyama T; Hashimoto K; Suzuki Y; Hirano R; Fukano R; Furukawa S
Platelets; 2010; 21(4):253-9. PubMed ID: 20433311
[TBL] [Abstract][Full Text] [Related]
39. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
Theron AJ; Steel HC; Tintinger GR; Gravett CM; Anderson R; Feldman C
J Immunol Res; 2014; 2014():608930. PubMed ID: 24971371
[TBL] [Abstract][Full Text] [Related]
40. [Leukotriene modifiers].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
